Clinical Trial Update: Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis

View source ↗

Summary

A completed clinical trial evaluating pharmacokinetic variability of infliximab in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: University Hospital, Tours | Conditions: Rheumatoid Arthritis | Status: COMPLETED